CTN shareholders are just chattels, page-2

First 2 Last

Share
Profile

Follow
Downanout

394 Posts.

33

01/11/17

15:27

Post #: 28402032
Share

Originally posted by Downanout ↑

This is from ramamba's post on the CGA thread.

https://hotcopper.com.au/search/search?type=post&users=ramamba

Here is the original AFR article that ramamba refers to. http://www.copyright link/business/...oubouras-charts-retail-course-20171029-gzapvv

Inter alia, Switzer is quoted as referring to : "the sale of [Contango MicroCap]"

Well that's a Freudian slip if ever there was one.

Contango Microcap (CTN) was never CGA's to sell.

Presumably what the article is actually referring to is that CGA have assigned to Naos the rights to manage CTN's funds on a long term lease.

But the right to manage CTN's funds wasn't CGA's to lease out either, or at least it shouldn't be.
The only way CGA could enter into that arrangement with Naos with a straight face is if CGA was confident that they had the CTN directors in their pocket.

Why did the CTN directors acquiesce to the transfer of the management of CTN funds to Naos?
The words egregious disregard of director's duties spring to my mind.

Naos can probably manage CTN's funds better than CGA, but given CGA's recent performance, that is a very low bar.

Why Naos? Why not some other investment manager?
Where was the due diligence on the part of the CTN board in the selection of investment manager?

WTF do the CTN directors think they are there for? To be CGA's hand maidens?

CTN directors are not there to serve the interests of CGA .

cheers

These are my opinions only. Nothing that I have written here should be construed as disparagement of any of the parties or entities involved. For all I know, all of the parties and entities may be completely convinced of the correctness of their actions and be acting from the highest possible motives with all due skill and care in accord with their various responsibilities and obligations. Any figures and facts are mentioned in good faith but I accept no responsibility for their accuracy.

Expand

Correction: I don't hold CGA. I wouldn't touch it with someone else's money!

CGA Price at posting: 62.0¢ Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 1 more message in this thread...

First 2 Last

Add CGA (ASX) to my watchlist

CTN shareholders are just chattels, page-2

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Resolute shares bounce back as second payment made to Mali government to secure workers' release

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game